Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Palliative cancer care - nausea & vomiting - Management
How should I manage nausea and vomiting at the end of life?

  • Try simple measures to relieve symptoms.
  • If an anti-emetic already controls symptoms well:
    • Continue with the same drug.
    • Give the same drug by syringe driver if the person becomes unable to take oral medication. If an injectable form is not available, use a drug with a similar mode of action.
  • For new or uncontrolled nausea and vomiting:
    • If appropriate, try to determine the underlying cause of nausea and vomiting and manage accordingly (see Scenario: Nausea and vomiting - management).
    • Otherwise give levomepromazine, 6.25 mg once daily by subcutaneous injection. Repeat the dose after 1 hour if needed.
    • If a repeat dose is needed, start levomepromazine by continuous subcutaneous injection (CSCI):
      • Start at a dose of 12.5 mg in 24 hours by CSCI, plus a 6.25 mg subcutaneous injection as needed.
      • If one or more extra doses are needed, increase the dose to 25 mg in 24 hours.
    • If symptoms remain uncontrolled, contact the local palliative care team for advice.
  • Review the effectiveness of anti-emetic treatment every 24 hours.

In depth

© NHS Institute for Innovation and Improvement